Drug Trial Radar · NCT04090957
Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort II)
Last checked: Nov 20, 2026Latest source record: Dec 26, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,015
Actual
Start
Sep 27, 2019
Primary completion
Aug 18, 2022
Study completion Aug 18, 2022
Sponsor
- Lead sponsor
- EstetraIndustry
- Sponsor type
- Industry
- Collaborators
- ICON Clinical Research
- First posted
- Sep 16, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 40 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
A two-part study designed to evaluate the effect of Estetrol (E4) 15 mg, 20 mg, or placebo on the severity and frequency of vasomotor symptoms (VMS) in the Efficacy Study Part and the safety of E4 20 mg in the Safety Study Part.
Conditions
- Vasomotor Symptoms
- Menopausal Symptoms
Interventions
Estetrol oral tabletDrug
Estetrol oral tablet, administered orally once daily.
Placebo oral tabletDrug
Placebo oral tablet, administered orally once daily.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Change in Weekly Frequency of Moderate to Severe Vasomotor Symptoms (VMS) From Baseline to Week 4 and Week 12 -- (Efficacy Study Part)Time frame: Week 0 (Baseline), Week 4, Week 12.
- Mean Change in Severity of Moderate to Severe Vasomotor Symptoms (VMS) From Baseline to Week 4 and Week 12 -- (Efficacy Study Part)Time frame: Week 0 (Baseline), Week 4, Week 12.
Locations
117 sites in 2 countries. Site status is shown where the registry gives one.
Estetra Study Site
Birmingham, Alabama
Estetra Study Site
Birmingham, Alabama
Estetra Study Site
Birmingham, Alabama
Estetra Study Site
Dothan, Alabama
Estetra Study Site
Phoenix, Arizona
Estetra Study Site
Phoenix, Arizona
Estetra Study Site
Tempe, Arizona
Estetra Study Site
Tucson, Arizona
Estetra Study Site
Tucson, Arizona
Estetra Study Site
Tucson, Arizona
Estetra Study Site
Tucson, Arizona
Estetra Study Site
Little Rock, Arkansas
Estetra Study Site
Bellflower, California
Estetra Study Site
Canoga Park, California
Estetra Study Site
Chula Vista, California
Estetra Study Site
Huntington Beach, California
Estetra Study Site
La Mesa, California
Estetra Study Site
Lincoln, California
Estetra Study Site
Los Angeles, California
Estetra Study Site
Pomona, California
Estetra Study Site
Sacramento, California
Estetra Study Site
San Diego, California
Estetra Study Site
San Diego, California
Estetra Study Site
Santa Ana, California
Estetra Study Site
Thousand Oaks, California
Estetra Study Site
West Covina, California
Estetra Study Site
Colorado Springs, Colorado
Estetra Study Site
Denver, Colorado
Estetra Study Site
Crystal River, Florida
Estetra Study Site
Jacksonville, Florida
Estetra Study Site
Jacksonville, Florida
Estetra Study Site
Miami, Florida
Estetra Study Site
Miami, Florida
Estetra Study Site
Miami, Florida
Estetra Study Site
Miami Lakes, Florida
Estetra Study Site
New Port Richey, Florida
Estetra Study Site
Ocoee, Florida
Estetra Study Site
Orlando, Florida
Estetra Study Site
Sarasota, Florida
Estetra Study Site
West Palm Beach, Florida
Showing 40 of 117 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.